Pioneering Personalized Diagnostics

Oregon Health & Science University has been a pioneer in targeted therapeutics.  The Knight Cancer Institute is known worldwide for the development of Gleevec, one of the most successful targeted therapies in oncology.  The OHSU department of Medical Molecular Genetics is a center of excellence for rare genetic disorders.

The Knight Diagnostic Laboratories were formed to commercialize testing for targeted therapies. We provide advanced laboratory diagnostic services, as well as research and development services, for healthcare providers and pharmaceutical clients in the rapidly growing field of personalized medicine. Through our continual investments in new test development and adaptive technologies in the areas of oncology, infectious disease and rare genetic disorders, we provide a comprehensive menu of tests designed to meet the growing diagnostic needs for making personalized medicine a reality.

Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More